✦ LIBER ✦

Impact of BCR-ABL mutations on response to dasatinib after imatinib failure in elderly patients with chronic-phase chronic myeloid leukemia

✍ Scribed by Mario Tiribelli, Roberto Latagliata, Luigiana Luciano…

Book ID: 120775676
Publisher: Springer
Year: 2012
Tongue: English
Weight: 143 KB
Volume: 92
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-012-1591-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Response to Imatinib mesylate in chronic

Response to Imatinib mesylate in chronic myeloid leukemia patients with variant BCR-ABL fusion transcripts

✍ Pratibha Sharma; Lalit Kumar; Sujata Mohanty; Vinod Kochupillai 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 122 KB

Dynamics and management of cytopenias as

Dynamics and management of cytopenias associated with dasatinib therapy in patients with chronic myeloid leukemia in chronic phase after imatinib failure

✍ Alfonso Quintás-Cardama; Fabio Pires De Souza Santos; Hagop Kantarjian; Susan O' 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB 👁 2 views

## Abstract ## BACKGROUND: The incidence, dynamics, and management of cytopenias were investigated in patients with chronic myeloid leukemia in chronic phase (CP CML) who received dasatinib therapy after imatinib failure. ## METHODS: Data were analyzed from 130 patients with CP CML who were trea

Emerging kinetics of BCR–ABL1 mutations

Emerging kinetics of BCR–ABL1 mutations and their effect on disease outcomes in chronic myeloid leukemia patients with imatinib failure

✍ Lee-Yung Shih; Ming-Chung Kuo; Ching-Yuan Kuo; Tseng-Hsi Lin; Li-Yaun Bai; Tsai- 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 743 KB

Frequency and clinical significance of B

Frequency and clinical significance of BCR-ABL mutations in patients with chronic myeloid leukemia treated with imatinib mesylate

✍ Jabbour, E; Kantarjian, H; Jones, D; Talpaz, M; Bekele, N; O'Brien, S; Zhou, X; 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 134 KB

Dasatinib-associated major molecular res

Dasatinib-associated major molecular responses in patients with chronic myeloid leukemia in chronic phase following imatinib failure: response dynamics and predictive value

✍ Hochhaus, A; Müller, M C; Radich, J; Branford, S; Kantarjian, H M; Hanfstein, B; 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 255 KB

Treatment of patients (PTS) with chronic

Treatment of patients (PTS) with chronic myeloid leukemia (CML) and imatinib failure after developing BCR-ABL kinase mutations with allogeneic stem cell transplantation (ASCT)

✍ E. Jabbour; J. Cortes; M. De Lima; B. Andersson; S. Giralt; H. Kantarjian; R. Ch 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 57 KB